Skip to main content
. 2016 Apr 5;7(2):e00431-16. doi: 10.1128/mBio.00431-16

TABLE 2 .

Comparison of nucleotide and amino acid similarities of TiLV in Ecuador and Israel

Segment no. GenBank accession
no. (Israel TiLV)
Predicted ORF
length (aa)
Total no. of nt
mutations in coding
regiona,b
% identity with TiLV in coding region
aa change(s) in TiLV
from Israel vs TiLV
from Ecuadora
nt aa
1 KU751814 519 44 (37 s, 7 ns) 97.20 98.70 K41→R, V85→I,
G98→S, R104→K,
V130→I, K207→R,
P515→L
2 KU751815 457 31 (33 s, 4 ns) 97.70 99.10 G4→E, I61→T,
I228→V, R236→K
3 KU751816 419 22 (22 s, 0 ns) 98.40 100.00 None
4 KU751817 356 25 (21 s, 4 ns) 97.80 98.90 V33→A, A35→V,
S275→L, N319→D
5 KU751818 343 15 (12 s, 3 ns) 98.50 99.10 S4→A, I17→T,
R111→K
6 KU751819 317 17 (12 s, 3 ns) 98.20 99.10 Y8→C, S27→N,
I227→V
7 KU751820 195 12 (11 s, 1 ns) 98.00 100 F135→L
8 KU751821 174 7 (6 s, 1 ns) 98.70 99.40 G42→S
9 KU751822 118 4 (3 s, 1 ns) 99 99 D109→N
10 KU751823 113 4 (3 s, 1 ns) 99 99 G52→S
a

Submitted GenBank sequences of TiLV isolated from Israel.

b

s, synonymous mutation; ns, nonsynonymous mutation.